Eli Lilly & Company (NYSE: LLY)

DRUGS - Drug Manufacturers - Major

Health Care

Stock price data as of

Closing price: $1443.50
  • Support level
    $1229.57
  • Resistance level
    N/A
  • Beta
    0.4
  • RSI (14-day)
    75.0
  • LLY is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
  • LLY is one of this month's top performers with a return of 14.8 percent, beating 90 percent of stocks in the S&P-100.
  • Up 6.6 percent, LLY is one of this week's biggest gainers.
  • Volatility is forecast to fall over the next month.
  • With RSI > 70, LLY is overbought. Odds slightly favor a short-term price reversal.
  • Price broke above prior resistance level - a short-term bullish signal.

52-week range

52-week low 52-week high Price as % of range
$851.21 $1443.50 100.0%

Moving averages

200 day 50 day 20 day 10 day
$1109.32 $1241.08 $1356.24 $1410.94

Value at risk (VaR)

There is an estimated 5% probability that the stock price will fall by more than VaR in time period.

  • In the next week
    8.7%
  • In the next month
    18.3%
  • In the next year
    68.8%

Volatility estimates (annualized standard deviations)

Period Value
Historical (5 year) 32.6%
Last month 32.2%
Current estimate 32.0%
Next month forecast 32.4%